Influenza A/B Antigen Rapid Test
- Wizbiotech
- CE
- China
Influenza A/B Antigen Test is intended for the qualitative detection of Influenza A/Influenza B Antigen in oropharyngeal swab or nasopharyngeal swab specimens in vitro. It takes 15~20 minutes to get results.
Introduction
Seasonal influenza, or flu, is a highly contagious respiratory disease caused by any of several human influenza viruses that circulate globally and cause annual outbreaks of varying severity. Influenza viruses infect the nose, throat, and lungs and produce symptoms that include sudden fever, extreme fatigue, coughing, chills, and muscle aches. Serious complications include pneumonia. Each year, flu causes millions of illnesses worldwide and kills many thousands. It is especially dangerous for people who are very young or old or who have other conditions such as heart disease or asthma.
Benefits
Quick results: The flu rapid test provides results within 15-20 minutes, making it easier for doctors to diagnose and treat the patient swiftly.
Cost-effective: The influenza test is relatively inexpensive compared to other laboratory tests and can be performed in the doctor's office.
Early detection: Flu rapid tests can detect the flu virus in the early stages of the infection, allowing for timely treatment and minimizing the risk of complications.
Reduced transmission: Early identification of the flu virus through rapid testing can help prevent the spread of the virus to other individuals.
Convenience: Flu rapid tests can be performed in various settings, including clinics, hospitals, schools, and workplaces, providing convenience for the patient and the healthcare provider.
Product Specifications
Method | Colloidal Gold |
| Sample Type | Oropharyngeal swab , nasopharyngeal swab |
Time to Result | 15~20mins |
| Storage | 2~30 ℃/36~86℉ |
| Shelf Life | 12 months from date of manufacture |
Kit Size | 1/2/3/5/10/20/25/30/40/50/100/200 tests |
※ Refer to Package Insert for additional product information.
Product Performance
Influenza A WIZ Results | Influenza A Reference RT-PCR Results | PPA:97.79%(C.I.93.72%~99.25%) NPA:99.35%(C.I.98.59%~99.70%) OPA:99.15%(C.I.98.39%~99.55%) | ||
| POS | NEG | total | ||
| POS | 133 | 6 | 139 | |
| NEG | 3 | 916 | 919 | |
| total | 136 | 922 | 1058 | |
Influenza B WIZ Results | Influenza B Reference RT-PCR Results | PPA:96.69%(C.I.91.81%~98.71%) NPA:98.51%(C.I.97.51%~99.11%) OPA:98.30%(C.I.97.33%~98.92%) | ||
| POS | NEG | total | ||
| POS | 117 | 14 | 131 | |
| NEG | 4 | 923 | 927 | |
| total | 121 | 937 | 1058 | |
Applications
Outpatient Emergency Laboratory
Clinical Departments
Community Hospital
Laboratory Departments
Health Management Center
Clinic
Certification
